PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 130 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,494,000 | +109.9% | 141,641 | +10.1% | 0.00% | +100.0% |
| Q4 2018 | $2,617,000 | -82.7% | 128,617 | -60.9% | 0.00% | -60.0% |
| Q3 2018 | $15,098,000 | +294.2% | 329,272 | +408.5% | 0.01% | +66.7% |
| Q2 2018 | $3,830,000 | -19.7% | 64,758 | -7.6% | 0.00% | 0.0% |
| Q1 2018 | $4,767,000 | -58.8% | 70,051 | -40.2% | 0.00% | -62.5% |
| Q4 2017 | $11,572,000 | -25.6% | 117,071 | -9.8% | 0.01% | -27.3% |
| Q3 2017 | $15,544,000 | +44.5% | 129,806 | +5.4% | 0.01% | +37.5% |
| Q2 2017 | $10,760,000 | +201.7% | 123,114 | +28.4% | 0.01% | +166.7% |
| Q1 2017 | $3,567,000 | +5.6% | 95,884 | -12.8% | 0.00% | 0.0% |
| Q4 2016 | $3,377,000 | -39.7% | 109,997 | +31.7% | 0.00% | -25.0% |
| Q3 2016 | $5,602,000 | +137.4% | 83,552 | +5.5% | 0.00% | +100.0% |
| Q2 2016 | $2,360,000 | +8.9% | 79,231 | +7.3% | 0.00% | 0.0% |
| Q1 2016 | $2,168,000 | -62.2% | 73,808 | +0.8% | 0.00% | -50.0% |
| Q4 2015 | $5,739,000 | -6.3% | 73,199 | -10.0% | 0.00% | -20.0% |
| Q3 2015 | $6,127,000 | -42.9% | 81,301 | -11.5% | 0.01% | -37.5% |
| Q2 2015 | $10,723,000 | -56.8% | 91,843 | -12.7% | 0.01% | -52.9% |
| Q1 2015 | $24,835,000 | +25.8% | 105,186 | +0.9% | 0.02% | +21.4% |
| Q4 2014 | $19,734,000 | -23.9% | 104,263 | -4.0% | 0.01% | -22.2% |
| Q3 2014 | $25,919,000 | +253.0% | 108,644 | -2.3% | 0.02% | +260.0% |
| Q2 2014 | $7,342,000 | -35.4% | 111,238 | +2.0% | 0.01% | -37.5% |
| Q1 2014 | $11,360,000 | -1.4% | 109,085 | -2.0% | 0.01% | 0.0% |
| Q4 2013 | $11,524,000 | +92.2% | 111,314 | -0.4% | 0.01% | +60.0% |
| Q3 2013 | $5,997,000 | +20.3% | 111,766 | -0.5% | 0.01% | +25.0% |
| Q2 2013 | $4,983,000 | – | 112,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |